Cite
Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-alpha-2b treatment.
MLA
Biró, Adrienn, et al. “Serum Anti-Cholesterol Antibodies in Chronic Hepatitis-C Patients during IFN-Alpha-2b Treatment.” Immunobiology, vol. 207, no. 3, 2003, pp. 161–68. EBSCOhost, https://doi.org/10.1078/0171-2985-00229.
APA
Biró, A., Horváth, A., Varga, L., Nemesánszky, E., Csepregi, A., Dávid, K., Tolvaj, G., Ibrányi, E., Telegdy, L., Pár, A., Romics, L., Karádi, I., Horányi, M., Gervain, J., Ribiczey, P., Csöndes, M., & Füst, G. (2003). Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-alpha-2b treatment. Immunobiology, 207(3), 161–168. https://doi.org/10.1078/0171-2985-00229
Chicago
Biró, Adrienn, Anna Horváth, Lilian Varga, Elemér Nemesánszky, Antal Csepregi, Károly Dávid, Gyula Tolvaj, et al. 2003. “Serum Anti-Cholesterol Antibodies in Chronic Hepatitis-C Patients during IFN-Alpha-2b Treatment.” Immunobiology 207 (3): 161–68. doi:10.1078/0171-2985-00229.